Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Author:

Marina Neyssa M,Smeland Sigbjørn,Bielack Stefan S,Bernstein Mark,Jovic Gordana,Krailo Mark D,Hook Jane M,Arndt Carola,van den Berg Henk,Brennan Bernadette,Brichard Bénédicte,Brown Ken L B,Butterfass-Bahloul Trude,Calaminus Gabriele,Daldrup-Link Heike E,Eriksson Mikael,Gebhardt Mark C,Gelderblom Hans,Gerss Joachim,Goldsby Robert,Goorin Allen,Gorlick Richard,Grier Holcombe E,Hale Juliet P,Hall Kirsten Sundby,Hardes Jendrik,Hawkins Douglas S,Helmke Knut,Hogendoorn Pancras C W,Isakoff Michael S,Janeway Katherine A,Jürgens Heribert,Kager Leo,Kühne Thomas,Lau Ching C,Leavey Patrick J,Lessnick Stephen L,Mascarenhas Leo,Meyers Paul A,Mottl Hubert,Nathrath Michaela,Papai Zsuzsanna,Randall R Lor,Reichardt Peter,Renard Marleen,Safwat Akmal Ahmed,Schwartz Cindy L,Stevens Michael C G,Strauss Sandra J,Teot Lisa,Werner Mathias,Sydes Matthew R,Whelan Jeremy S

Publisher

Elsevier BV

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3